Yoshiya Tanaka | Medicine and Dentistry | Best Researcher Award

Posted on by Book of Award

Prof. Yoshiya Tanaka | Medicine and Dentistry | Best Researcher Award

University of Occupational and Environmental Health | Japan

Author Profile

Scopus

Orcid

🎓 Early Academic Pursuits

Prof. Yoshiya Tanaka embarked on his academic journey at the University of Occupational and Environmental Health, Japan (UOEH), where he earned his MD in 1984. His thirst for knowledge and commitment to medical research led him to pursue a PhD at the Graduate School of Medical Science, UOEH, which he completed in 1988. This strong academic foundation laid the groundwork for his exceptional career in internal medicine and rheumatology.

🌟 Professional Endeavors

Prof. Tanaka’s illustrious career began with a prestigious opportunity as a Visiting Fellow in the Experimental Immunology Branch at the National Cancer Institute, NIH, USA, from 1989 to 1992. Upon returning to Japan, he rapidly ascended the academic ladder, becoming a Professor and Chairman of the First Department of Internal Medicine at UOEH in 2000. His leadership and expertise earned him the role of Dean of the Graduate School of Medical Science at UOEH in 2017, followed by his appointment as Director of the International Center at UOEH in 2022.

🔬 Contributions and Research Focus

Prof. Tanaka has dedicated his career to advancing the field of rheumatology, clinical immunology, and inflammatory diseases. His research primarily focuses on rheumatoid arthritis, systemic lupus erythematosus, and novel therapeutic approaches, including Janus kinase (JAK) inhibitors and biologic therapies. His groundbreaking work on cytokine-targeting therapies has significantly influenced treatment strategies for autoimmune diseases. As a key member of multiple scientific societies, he has contributed to the Japanese College of Rheumatology (JCR), the Japanese Society of Clinical Immunology, and the Asia Pacific League of Associations for Rheumatology (APLAR). His editorial contributions include serving as an editor or associate editor for prestigious journals such as The Lancet Rheumatology, Annals of Rheumatic Diseases, and Arthritis Research & Therapy.

🏆 Accolades and Recognition

Prof. Tanaka's contributions to rheumatology and immunology have been recognized through numerous awards. In 2003, he received the Academic Award from the Japanese Society of Bone and Mineral Research (JSBMR), followed by the President Award from the Japanese College of Rheumatology in 2008. His outstanding research was acknowledged globally when he was honored with the Congress Award from the European Alliance of Associations for Rheumatology (EULAR) in 2009. In 2023, his lifelong contributions earned him the prestigious Honorary Award from EULAR.

🔍 Impact and Influence

With over 1,067 publications in English and an impressive h-index of 117, Prof. Tanaka's research has left an indelible mark on the field of rheumatology. His total impact factor of 6,402 underscores the significance of his work in shaping clinical practices worldwide. His seminal studies, including those published in Nature, The New England Journal of Medicine, and The Lancet, have influenced treatment protocols and deepened the understanding of inflammatory and autoimmune diseases. As a mentor, he has guided numerous young researchers, fostering the next generation of scientists and clinicians in Japan and beyond. His involvement in international collaborations has further solidified his role as a global leader in rheumatology research.

🌱 Legacy and Future Contributions

Prof. Tanaka’s legacy is defined by his relentless pursuit of scientific discovery and his commitment to improving patient care. His work in cytokine-targeted therapies and JAK inhibitors has paved the way for more effective and personalized treatments for autoimmune diseases. As he continues to lead groundbreaking research and mentor future medical professionals, his impact on the field will endure for generations to come. With his ongoing roles at UOEH and leadership positions in international rheumatology organizations, Prof. Tanaka remains at the forefront of medical innovation. His future contributions promise to further revolutionize treatment paradigms and enhance the quality of life for patients worldwide.

 

Publications

  • Article: Peripheral blood immunophenotypic diversity in patients with rheumatoid arthritis and its impact on therapeutic responsiveness
    Authors: S. Kubo, Y. Miyazaki, T. Nishino, S. Nakayamada, Y. Tanaka
    Journal: Annals of the Rheumatic Diseases
    Year: 2025

  • Article: Safety of baricitinib in Japanese patients with rheumatoid arthritis in clinical use: 3-year data of all-case postmarketing surveillance study
    Authors: N. Okamoto, T.A. Atsumi, M. Takagi, Y. Tanaka, M. Kuwana
    Journal: Modern Rheumatology
    Year: 2025

  • Article: Association of peripheral CD8+ T cell activation with disease activity and treatment resistance in systemic lupus erythematosus
    Authors: Y. Fujita, S. Nakayamada, S. Kubo, H. Tanaka, Y. Tanaka
    Journal: RMD Open
    Year: 2025

  • Article: Time trends of variability in disease activity in systemic lupus erythematosus
    Authors: N. Li, A.Y.B. Hoi, S.F. Luo, R.K. Kandane-Rathnayake, E.F. Morand
    Journal: Lupus Science and Medicine
    Year: 2025

  • Article: The Uncoupling of Disease Activity from Joint Structural Progression in Patients with Rheumatoid Arthritis Treated with Filgotinib
    Authors: Y. Tanaka, T.A. Atsumi, D. Aletaha, C. Watson, T. Takeuchi
    Journal: Rheumatology and Therapy
    Year: 2025

 

Yunlong Liu | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Posted on by Book of Award

Dr. Yunlong Liu | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Tiangong University | China

Author Profile

Orcid

🎓 Early Academic Pursuits

Dr. Yunlong Liu was born in August 1995 in Chengde, Hebei Province, China. His academic journey began with a strong foundation in the biological sciences, which led him to pursue a Ph.D. in Biochemistry and Molecular Biology at China Agricultural University from 2018 to 2023. During his doctoral studies, he delved into structural biology, focusing on unraveling the molecular mechanisms of transcriptional regulation mediated by nuclear receptors and other transcription factors. His exceptional research prowess and dedication earned him prestigious accolades, such as the National Ph.D. Scholarship and the Outstanding Doctoral Dissertation Award.

👨‍🏫 Professional Endeavors

Since August 2023, Dr. Liu has been serving as a Lecturer at the College of Life Sciences, Tiangong University. His transition from a promising Ph.D. scholar to a faculty member highlights his commitment to academia and scientific research. His role involves not only imparting knowledge to the next generation of scientists but also continuing his cutting-edge research in structural biology and transcriptional regulation.

🔬 Contributions and Research Focus

Dr. Liu's research is centered on understanding the structural and functional dynamics of nuclear receptors and transcription factors. He has determined seven crystal structures of protein monomers, protein-protein complexes, and protein-nucleic acid complexes. His work led to the identification of a nuclear receptor inhibitor with 100-fold enhanced efficacy, marking a significant breakthrough in molecular biology. His research contributions are reflected in his publications, including a sole first-author paper in Nucleic Acids Research with an impact factor of 19.16, as well as co-authored papers in Cell Discovery with an impact factor of 38.1 and the Journal of Biological Chemistry with an impact factor of 5.8. He has also played a crucial role in leading prestigious research projects, such as the National Natural Science Foundation of China and the Tianjin Top Scientist Studio Program, securing substantial funding for his research. His studies contribute to a deeper understanding of transcriptional regulation, a crucial aspect in fields like genetics, cancer research, and pharmaceutical development.

🏆 Accolades and Recognition

Dr. Liu’s remarkable contributions to structural biology have been acknowledged with numerous awards. He received the Outstanding Doctoral Dissertation Award and the Outstanding Ph.D. Graduate Award from China Agricultural University in 2023. In 2022, he was awarded the National Ph.D. Scholarship, ranking second in his college. During his undergraduate years, he secured the Second Prize in the National Mathematical Modeling Competition in 2016 and was a recipient of the National Inspirational Scholarships in 2016 and 2017. He was also honored as an Outstanding Graduate in 2018. These accolades highlight his exceptional academic excellence and research contributions.

🌍 Impact and Influence

Dr. Liu’s groundbreaking work has significantly influenced the field of structural biology, particularly in transcriptional regulation. His high-impact publications and research findings pave the way for advancements in drug discovery, genetic regulation, and medical therapeutics. By identifying novel molecular mechanisms and inhibitors, his work has the potential to drive innovations in treating diseases linked to transcriptional dysregulation, such as cancer and metabolic disorders. Beyond research, Dr. Liu's role as a lecturer enables him to inspire and mentor young scientists. His transition from a student to a faculty member positions him as a role model for aspiring biochemists and molecular biologists.

🚀 Legacy and Future Contributions

Looking ahead, Dr. Liu is set to make even more substantial contributions to the scientific community. His ongoing research projects, including those funded by national and provincial grants, will continue to advance the understanding of transcriptional regulation. With his expertise in structural biology and biochemistry, he is poised to make further discoveries that will shape the future of molecular medicine. As he continues his academic journey, Dr. Liu’s legacy will be defined by his unwavering dedication to science, his contributions to groundbreaking research, and his role in nurturing the next generation of scientists. His story is a testament to the power of perseverance, intellect, and scientific curiosity in pushing the boundaries of knowledge.

 

Publications

  • 📄The Progress and Evolving Trends in Nucleic-Acid-Based Therapies
    Authors: Yunlong Liu, Chunmiao Wang, Xiuping Fu, Mengtian Ren
    Journal: Biomolecules
    Year: 2025

  • 📄Structural Basis of Nucleic Acid Recognition and 6mA Demethylation by Caenorhabditis elegans NMAD-1A
    Authors: Guohui Shang, Meiting Yang, Min Li, Lulu Ma, Yunlong Liu, Jun Ma, Yiyun Chen, Xue Wang, Shilong Fan, Mengjia Xie, et al.
    Journal: International Journal of Molecular Sciences
    Year: 2024

  • 📄Structures of Human TR4LBD–JAZF1 and TR4DBD–DNA Complexes Reveal the Molecular Basis of Transcriptional Regulation
    Authors: Yunlong Liu, Lulu Ma, Min Li, Zizi Tian, Meiting Yang, Xi Wu, Xue Wang, Guohui Shang, Mengjia Xie, Yiyun Chen, et al.
    Journal: Nucleic Acids Research
    Year: 2023

  • 📄Structures of MPND Reveal the Molecular Recognition of Nucleosomes
    Authors: Meiting Yang, Xiaorong Li, Zizi Tian, Lulu Ma, Jun Ma, Yunlong Liu, Guohui Shang, Ailing Liang, Wei Wu, Zhongzhou Chen
    Journal: International Journal of Molecular Sciences
    Year: 2023

  • 📄Structural Insights into the Interactions and Epigenetic Functions of Human Nucleic Acid Repair Protein ALKBH6
    Authors: Lulu Ma, Hongyun Lu, Zizi Tian, Meiting Yang, Jun Ma, Guohui Shang, Yunlong Liu, Mengjia Xie, Guoguo Wang, Wei Wu, et al.
    Journal: Journal of Biological Chemistry
    Year: 2022

 

Theopista Lotto | Health Professions | Best Research Article Award

Posted on by Book of Award

Ms. Theopista Lotto | Health Professions | Best Research Article Award

Ifakara Health Institute | Tanzania

Author Profile

Orcid

🎓 Early Academic Pursuits

Ms. Theopista Lotto embarked on her academic journey with a deep commitment to healthcare and research. She earned her Bachelor of Pharmacy from Muhimbili University, Dar es Salaam, Tanzania (2003-2007), laying a strong foundation in pharmaceutical sciences. Her passion for healthcare monitoring and evaluation led her to pursue an MSc in Health Monitoring and Evaluation at Mzumbe University, Morogoro, Tanzania (2013-2015). Further advancing her expertise, she attained a PhD in Epidemiology and Public Health from Swiss TPH, Switzerland (2021-2023), equipping her with cutting-edge skills in public health research and antimicrobial resistance (AMR) studies.

💼 Professional Endeavors

Ms. Lotto has demonstrated exceptional leadership and expertise in public health, antimicrobial stewardship, and pharmaceutical research through her extensive professional journey. She currently serves as an M&E Advisor for the CDC Project on Sustainable Health System Strengthening at Mzumbe University (2024-Present), where she designs and implements evaluation frameworks and supports national health initiatives. Her role as a Technical Expert and In-Country Consultant for the Commonwealth Pharmacist Association (2023-Present) underscores her influence in antimicrobial stewardship, ensuring that healthcare programs align with Tanzania’s National Action Plan on AMR. Previously, she was a Research Scientist at Ifakara Health Institute (2020-2024), where she led multiple AMR surveillance projects and cross-sectional studies on antimicrobial use. Her earlier career includes impactful roles such as M&E Advisor at Tanzania Institute of Monitoring and Evaluation (2019-2020), DHIS2 Coordinator at Mbeya District Council (2015-2019), and District Pharmacist at Mbeya District Council (2009-2015). These positions highlight her extensive experience in data-driven decision-making, pharmaceutical logistics, and healthcare policy implementation.

🔬 Contributions and Research Focus

Ms. Lotto’s research focuses on antimicrobial resistance, antimicrobial stewardship, public health surveillance, and health system strengthening. She has played a pivotal role in:

  • Designing and leading AMU & AMS projects at Ifakara Health Institute, conducting large-scale community surveys to assess antimicrobial use in Tanzania.
  • Implementing electronic Clinical Decision Support Algorithms (CDSA) to promote antibiotic stewardship and improve pediatric healthcare outcomes.
  • Enhancing health monitoring systems through her expertise in Health Information Systems (DHIS2) and supporting national stakeholders with data-driven decision-making.

Her research has significantly contributed to the development of antimicrobial resistance policies, ensuring that Tanzania aligns with global AMR mitigation strategies.

🏆 Accolades and Recognition

Ms. Lotto’s contributions have earned her recognition as a leading researcher in public health and pharmacy. She has been instrumental in multiple government and international health projects, showcasing her ability to foster cross-sector collaborations with organizations like the CDC, Commonwealth Pharmacist Association, and Ifakara Health Institute. Her technical expertise in antimicrobial stewardship has positioned her as a sought-after consultant in Tanzania’s healthcare system.

🌍 Impact and Influence

Ms. Lotto’s work has had a far-reaching impact on Tanzania’s public health landscape. She has:

  • Strengthened AMR surveillance and antimicrobial stewardship programs at a national level.
  • Improved healthcare monitoring and evaluation frameworks through innovative data collection and analysis.
  • Supported policy formulation and implementation, working closely with government ministries and international health bodies.
  • Provided training and mentorship to healthcare professionals, ensuring sustainable knowledge transfer in pharmaceutical management and public health research.

Her influence extends beyond research; she actively engages policymakers, healthcare practitioners, and academic institutions to drive meaningful change in the fight against AMR.

🔮 Legacy and Future Contributions

As a visionary leader in public health and pharmacy, Ms. Lotto continues to pave the way for stronger healthcare systems in Tanzania. Her future contributions are expected to focus on:

  • Expanding AMR research to include more comprehensive national and regional studies.
  • Developing innovative pharmaceutical management tools to optimize drug distribution and usage.
  • Strengthening international collaborations to combat antimicrobial resistance on a global scale.
  • Training and mentoring the next generation of researchers in epidemiology and public health.

With her unwavering dedication and expertise, Ms. Lotto is set to leave a lasting legacy in global health research and pharmaceutical sciences, ensuring sustainable and evidence-based healthcare practices for generations to come.

 

Publications

📄 Population-Based Prevalence of Antibiotic Residuals in Low, Moderate and High Malaria Endemicity Areas in Tanzania
Author(s): Theopista Lotto, Joanna Gallay, Martin Zuakulu, Beatrice Ternon, Laurent Arthur Decosterd, Alexandra V. Kulinkina, Blaise Genton
Journal: Antibiotics
Year: 2025

Bin Zheng | Biomedicine | Best Researcher Award

Posted on by Book of Award

Prof. Dr. Bin Zheng | Biomedicine | Best Researcher Award

Tianjin University | China

Author Profile

Scopus

Orcid

Early Academic Pursuits 🌱

Prof. Dr. Bin Zheng’s academic journey began with a solid foundation in medical engineering and translational medicine. He further honed his expertise as a postdoctoral fellow at the Caroline School of Medicine, Sweden, laying the groundwork for a prolific career. His early pursuits in biomaterials and nanotechnology provided a strong base for his subsequent innovations and contributions to biomedical sciences.

Professional Endeavors 🏢

As a professor at Tianjin University's Academy of Medical Engineering and Translational Medicine, Dr. Zheng has led numerous research projects, including 10 completed and 6 ongoing endeavors. With over 30 impactful SCI publications, his work has gained recognition on a global scale. His collaborations with leading companies have fostered breakthroughs in cellular manufacturing and delivery technologies, enhancing both academic and industrial applications.

Contributions and Research Focus 🔬

Dr. Zheng’s work spans a wide range of fields, including biomaterials, cancer research, cellular microbiology, immunity, and nanobiotechnology. He has developed innovative therapeutic agents, including a nebulizable anti-bacterial spray targeting exosomes and stem cell extracts. His patents—70 published and 14 in progress—reflect his commitment to bridging the gap between laboratory research and clinical application.

Accolades and Recognition 🏆

Dr. Zheng’s outstanding contributions have earned him numerous awards, such as the Excellent Doctoral Dissertation of Tianjin Municipality and the First Prize for Innovative Achievements from the China Industry-University-Research Cooperation Association. Under his mentorship, graduate students have garnered over 20 prestigious awards, solidifying his role as an influential academic leader.

Impact and Influence 🌍

His research has been clinically translated and widely reported by media outlets like Science and Technology Daily and Science Net. As an editorial board member of prestigious journals, Dr. Zheng also influences the direction of global biomedical research. His international collaborations and contributions to standards like the Belt and Road LSEA 0006-2022 standard underscore his global impact.

Legacy and Future Contributions 🌟

Prof. Dr. Bin Zheng’s legacy lies in his innovative methodologies and translational focus, which continue to inspire the next generation of researchers. With ongoing projects in cutting-edge fields like optogenetics and cellular precision manufacturing, his future contributions are set to redefine the boundaries of medical engineering and translational medicine.

 

Publications

📄 Microorganism microneedle micro-engine depth drug delivery
Author(s): Zheng, B., Li, Q., Fang, L., Cheng, S.-X., Zhang, X.
Journal: Nature Communications
Year: 2024

📄 Near-infrared remote triggering of bio-enzyme activation to control intestinal colonization by orally administered microorganisms
Author(s): Sun, W., Yun, F., Guo, Q., Zheng, B., Ruan, X.
Journal: Acta Biomaterialia
Year: 2024

📄 Surface nanocoating-based universal platform for programmed delivery of microorganisms in complicated digestive tract
Author(s): Du, Y., Guo, H.L., Su, X., Wang, T., Zheng, B.
Journal: Journal of Colloid and Interface Science
Year: 2024

📄 A self-assembling bioactive oligopeptide hydrogel for the treatment of edema following prepuce surgery
Author(s): Liu, J., Pei, Y., Huang, Y., Chen, L., Zhou, Y.
Journal: Journal of Materials Chemistry B
Year: 2024

📄 NIR-Remote Selectively Triggered Buprenorphine Hydrochloride Release from Microneedle Patches for the Treatment of Neuropathic Pain
Author(s): Han, H., Li, B., Yang, R., Bai, Y., Yu, Y.
Journal: ACS Biomaterials Science and Engineering
Year: 2024

 

Simeon Ikechukwu Egba | Biochemistry, Genetics and Molecular Biology | Editorial Board Member

Posted on by Book of Award

Dr. Simeon Ikechukwu Egba | Biochemistry, Genetics and Molecular Biology | Editorial Board Member

Kampala International University | Uganda

Author Profile

Scopus

Orcid

Early Academic Pursuits 📚

Dr. Simeon Ikechukwu Egba’s academic journey began with his foundational education in Nigeria. After completing his secondary education at Community Secondary School, Eha-ohuala and Special Science School, Igbeagu, he pursued his undergraduate studies at the University of Nigeria, Nsukka, where he earned a Bachelor’s degree in Biochemistry in 2000. His academic curiosity and dedication to biochemistry led him to continue his studies at the same institution, earning a Master's degree in 2010 and later a Ph.D. in Biochemistry in 2014. His commitment to furthering his expertise in medical laboratory sciences was also demonstrated through studies at Nnamdi Azikiwe University Teaching Hospital-Nnewi.

Professional Endeavors 🏫

Dr. Egba's professional journey in academia spans over twelve years, during which he has held numerous positions that showcase his leadership and commitment to research and education. He has served as a lecturer in Biochemistry at various institutions, including Michael Okpara University of Agriculture, Umudike, and currently at Kampala International University, Uganda. His responsibilities have included teaching courses in biochemistry, overseeing laboratory sessions, and coordinating various academic functions such as the Student Industrial Work Experience Scheme (SIWES). Additionally, he has taken on key administrative roles, including being a member of the University Senate, and has led projects in research and curriculum development.

Contributions and Research Focus 🔬

Dr. Egba’s research interests are diverse and impactful, focusing on medical biochemistry, natural products, immune-modulation, endocrinology, and biochemical toxicology. His research has not only expanded the scientific understanding of these fields but has also contributed to real-world applications, such as exploring the immune-modulatory effects of herbal extracts and investigating glucose transport enhancement. He has made significant contributions to diabetes research, with several studies on anti-diabetic poly-herbal formulas. His scholarly work includes over 70 publications and successful supervision of 18 postgraduate students, many of whom have gone on to have successful academic careers.

Accolades and Recognition 🏅

Dr. Egba's academic excellence has earned him recognition within the scientific community. He has received multiple research grants, including those from the TETFUND, for projects that focus on diabetes and immunological responses. His dedication to his field is evident not only in his numerous publications but also in his role as a mentor, guiding over 150 undergraduate students through their research projects, many of whom have received scholarships to pursue postgraduate studies worldwide. Dr. Egba is an active member of the Nigerian Society of Biochemistry and Molecular Biology (NSBMB) and the Association of Medical Laboratory Scientists of Nigeria (AMLSN).

Impact and Influence 🌍

Dr. Egba’s impact extends beyond academia through his direct contributions to research and the development of future scholars. His research on the biochemical effects of natural products has influenced studies on immune-modulation and endocrinology, providing valuable insights into how natural compounds can influence human health. He has also played a pivotal role in improving the quality of laboratory practices and biochemistry education. His students, both undergraduate and postgraduate, continue to carry forward his legacy in research and academia, furthering his influence globally.

Legacy and Future Contributions 🌟

Dr. Egba’s future contributions are poised to further cement his legacy as a leading academic and researcher. His ongoing research projects aim to continue advancing the understanding of the biochemical pathways in diseases such as diabetes, and his work with poly-herbal formulations could have significant therapeutic implications. As he trains the next generation of biochemists and medical laboratory scientists, Dr. Egba’s influence will continue to shape the future of research and medical science, particularly in the fields of immunology and endocrinology.

Publication

  • 📜 Effects of exposure to volatile organic compounds (VOCs) content from paint on automobile paint workers in Nsukka, South Eastern Nigeria
    Authors: Ogbodo, J.O., Egba, S.I., Ogbodo, C.G., Onwurah, I.E., Njoku, O.U.
    Journal: Heliyon
    Year: 2024
  • 📜 Understanding apoptosis in sickle cell anemia patients: Mechanisms and implications
    Authors: Obeagu, E.I., Ubosi, N.I., Obeagu, G.U., Egba, S.I., Bluth, M.H.
    Journal: Medicine (United States)
    Year: 2024
  • 📜 Evaluation of fertility hormones and biochemical stress initiated by toxicant in diet prepared with fish smoked with polyethylene (plastic) materials as a fuel source
    Authors: Uhuo, E.N., Egba, S.I., Alaebo, P.O., Obike, C.A., Ede, I.S.
    Journal: Comparative Clinical Pathology
    Year: 2023
  • 📜 Antioxidative properties of Adansonia digitata L. (baobab) leaf extract exert protective effect on doxorubicin-induced cardiac toxicity in Wistar rats
    Authors: Uhuo, E.N., Egba, S.I., Nwuke, P.C., Obike, C.A., Kelechi, G.K.
    Journal: Clinical Nutrition Open Science
    Year: 2022
  • 📜 Renoprotective effects of Adansonia digitata leaf extract on renal function and histopathological changes in vancomycin-induced nephrotoxicity in Wistar rats
    Authors: Uhuo, E.N., Egba, S.I., Nwuke, P.N., Odinamadu, H.
    Journal: Comparative Clinical Pathology
    Year: 2022

 

Rengui Saxu | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Posted on by Book of Award

Dr. Rengui Saxu | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

China Pharmaceutical University | China                    

Author Profile

Orcid

Early Academic Pursuits 🎓

Dr. Rengui Saxu began his academic journey at Shenyang Medical College, where he pursued a degree in Clinical Medicine Science from 2012 to 2017. During his studies, he completed an internship at Shenyang Central Hospital in 2017, gaining hands-on experience in clinical practice. His academic dedication earned him the National Encouragement Scholarship and the title of Outstanding Graduate, marking his potential as a rising scholar in the field of medicine. Continuing his academic path, Dr. Saxu pursued a Master of Pharmacy Engineering at Tianjin University of Science & Technology from 2017 to 2020. During this time, he took on leadership roles, notably serving as the Head of the Academic Department of the University Graduate Association. His work in pharmacy engineering was recognized with the Zhixing Scholarship for Postgraduate Students.

Professional Endeavors 🏅

Dr. Saxu is currently engaged in advanced research as a Ph.D. candidate in Pharmacology at China Pharmaceutical University (2021-2025). He works under the supervision of Yong Yang, a prominent figure in pharmacological research, and Harvest F. Gu, Chief Scientist at Karolinska Medical School in Sweden. His research spans crucial areas in pharmacology, focusing on drug development and the mechanisms of disease, particularly in relation to diabetes, kidney disease, and cancer.

Contributions and Research Focus 🔬

Dr. Saxu's research contributions are vast, with a focus on pharmacological innovations and therapeutic interventions for diseases like diabetes and cancer. One of his notable patents is a Chinese patent for a method involving selenium-substituted axitinib, which offers anti-tumor applications. His academic publications reflect his deep involvement in cutting-edge research:

  • His studies on asymmetries in adrenal glands and their role in glucocorticoid production provide insights into diabetes-related obesity.
  • He has explored the therapeutic potential of Abelmoschus manihot (L.) in treating diabetic nephropathy via the gut-kidney axis, contributing to the advancement of herbal medicine in disease management.
  • Dr. Saxu has also investigated how Huangkui capsules inhibit aldosterone synthesis in diabetic kidney disease, a promising direction for traditional Chinese medicine.

Accolades and Recognition 🏆

Dr. Saxu's academic excellence has been recognized through numerous prestigious awards:

  • National Encouragement Scholarship
  • Zhixing Scholarship for Postgraduate Students
  • Doctoral Research Incentive Scholarship
  • Outstanding Doctoral Scholarship

These accolades reflect his commitment to research and innovation in the field of pharmacology.

Impact and Influence 🌍

Dr. Saxu's research has had a considerable impact on the medical and pharmacological fields, particularly in the treatment of diabetes and kidney disease. His work on drug therapy and natural compound-based treatments has opened new avenues for understanding and combating complex diseases. His research not only influences medical practices in China but also has international implications, especially in areas related to drug efficacy and safety.

Legacy and Future Contributions 🚀

Dr. Saxu’s future contributions are poised to advance pharmacological research significantly, especially in the areas of cancer therapy and chronic disease management. As a researcher under highly esteemed mentors like Yong Yang and Harvest F. Gu, his ongoing work will likely lead to breakthroughs in targeted therapies and personalized medicine. In the years to come, Dr. Saxu's work will continue to shape the landscape of pharmaceutical sciences, offering hope for more effective and less harmful treatment options. His contributions to medical research, especially in oncology and diabetes, will leave a lasting legacy in global healthcare.

 

Publications

📜 Higher Steroid Production in the Right Adrenal Gland Compared to the Left One in db/db Mice, a Model of Type 2 Diabetic Obesity

  • Authors: Rengui Saxu, Qiming Luo, Yong Yang, Harvest F. Gu
  • Journal: International Journal of Molecular Sciences
  • Year: 2024

📜 Asymmetries of Left and Right Adrenal Glands in Neural Innervation and Glucocorticoids Production

  • Authors: Rengui Saxu, Yong Yang, Harvest F. Gu
  • Journal: International Journal of Molecular Sciences
  • Year: 2023

 

Sejal Parekh | Health Professions | Best Researcher Award

Posted on by Book of Award

Ms. Sejal Parekh | Health Professions | Best Researcher Award

NHS England | United Kingdom

Author Profile

Orcid

Early Academic Pursuits 📚

Sejal Parekh embarked on her academic journey with a Master of Pharmacy (MPharm) from University College London, where she honed her expertise in pharmaceutical sciences. In 2017, she furthered her education with a Master’s in Clinical Research (MRes), funded by the NIHR. This strong academic foundation in pharmacy and clinical research equipped her with a comprehensive understanding of quantitative and qualitative research methodologies.

Professional Endeavors 💼

Sejal’s career spans diverse roles within both hospital and community pharmacy settings. She has been instrumental in leading national quality improvement initiatives, particularly as a Senior Project/Policy Manager at NHS England. Her role involved developing criteria for the Pharmacy Quality Scheme (PQS) and liaising with stakeholders like NHS Digital, Public Health England, and the Pharmaceutical Services Negotiating Committee (PSNC). Her work, particularly during the pandemic, led to the implementation of infection control measures, influencing community pharmacy operations across the country.

Contributions and Research Focus 🔬

Sejal's contributions are deeply rooted in antimicrobial stewardship, service delivery, and policy writing. A notable project was her leadership in the NSAID safety audit within community pharmacies, where she identified a significant gap in gastroprotection for patients on NSAIDs. Her findings prompted recommendations that improved patient safety in primary care, aligning with the WHO Global Patient Safety Challenge. Sejal has co-authored several reports and articles that are widely recognized within the medical community.

Accolades and Recognition 🏆

Throughout her career, Sejal has received several awards, including:

  • HSJ Winner: Patient Safety Team of 2023 for her work on the Pharmacy Quality Scheme.
  • She was also the Pre-registration Trainee Pharmacist of the Year for London (2003) and a GlaxoSmithKline Prize recipient for her work on smoking cessation.

Her accolades underscore her dedication to patient safety and innovative pharmaceutical care.

Impact and Influence 🌍

Sejal's work has had a profound impact on community pharmacy in the UK. Her development of safer prescribing initiatives and infection control protocols, especially during the COVID-19 pandemic, has contributed to national improvements in healthcare delivery. Her ability to collaborate across teams and organizations has resulted in smoother policy implementations and improved patient outcomes.

Legacy and Future Contributions 🌟

As a thought leader in pharmacy, Sejal Parekh’s legacy is built upon her pioneering work in antimicrobial stewardship and patient safety. Her ongoing contributions to the Pharmacy Quality Scheme and national healthcare initiatives demonstrate her commitment to improving service quality. With her recent role as a Programme Manager for NHS England, Sejal is poised to continue making impactful changes in the healthcare landscape. Her future endeavors will likely include further innovations in pharmacy services, ensuring continued excellence in patient care.

 

Publications

  • 📚 "An Evaluation of Oral Anticoagulant Safety Indicators by England’s Community Pharmacies"
    Journal: Pharmacy, Year: 2024
    Authors: Sejal Parekh, Lingqian Xu, Carina Livingstone
  • 📚 "Responding to Urinary Tract Infection Symptoms in England’s Community Pharmacies"
    Journal: Antibiotics, Year: 2023
    Authors: Sejal Parekh, Kieran S Hand, Lingqian Xu, Victoria Roberts, Fionna Pursey, Diane Ashiru-Oredope, Donna Lecky
  • 📚 "The National Implementation of a Community Pharmacy Antimicrobial Stewardship Intervention (PAMSI) through the English Pharmacy Quality Scheme 2020 to 2022"
    Journal: Antibiotics, Year: 2023
    Authors: Catherine Hayes, Sejal Parekh, Donna Lecky, Jill Loader, Carry Triggs-Hodge, Diane Ashiru-Oredope
  • 📚 "ESPAUR Report 2021 to 2022 Chapter 5: NHS England Improvement and Assurance Schemes"
    Journal: Medical Sciences Forum, Year: 2023
    Authors: Kieran S Hand, Diane Ashiru-Oredope, Elizabeth Beech, Sabine Bou-Antoun, Gillian Damant, Naomi Fleming, Catherine Hayes, Philip Howard, Conor Jamieson, Monsey McLeod et al.
  • 📚 "National Antimicrobial Stewardship Activities in Primary and Secondary Care in England 2021–22 (ESPAUR Report)"
    Journal: Medical Sciences Forum, Year: 2023
    Authors: Ella Casale, Catherine Hayes, Donna Lecky, Luke O’Neil, Eirwen Sides, Emily Cooper, Fionna Pursey, Sejal Parekh, Eleanor J. Harvey, Diane Ashiru-Oredope

 

Fang Wang | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Posted on by Book of Award

Dr. Fang Wang | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Maastricht University | Netherlands

Author Profile

Scopus

Orcid

Early Academic Pursuits 📚

Dr. Fang Wang's academic journey began with a Bachelor’s degree in Pharmacology from Nanchang University, where she developed an oxidative stress model in LO2 cells to test stress amelioration compounds. She continued her studies with a Master's degree in Cell Biology at the same university, focusing on the role of progesterone adiponectin receptor 7 in reproduction and differences in protein post-translational modifications. Currently, she is pursuing a PhD in Cell Biology at Maastricht University, investigating substrate metabolism in diabetic cardiomyopathy and novel treatments using bioactive components from Traditional Chinese Medicine.

Professional Endeavors 🔬

With over seven years of experience, Dr. Wang has built a strong foundation in preclinical research, drug development, scientific communication, and project management. Her professional career includes internships at Shanghai ChemPartner Co., Ltd. and Jiangxi Zhby Biotech Co. Ltd., where she gained hands-on experience in molecular biology testing and research planning. Her current roles involve significant contributions to research in metabolic disorders and male infertility, with a focus on protein translocation and endosome pH regulation.

Contributions and Research Focus 🌟

Dr. Wang’s research primarily targets the intersection of metabolic disorders and drug development, specifically focusing on diabetic cardiomyopathy and the impact of Traditional Chinese Medicine on cardiac health. Her work includes investigating novel treatment strategies and exploring the mechanisms of substrate metabolism, protein translocation, and endosome pH regulation. Her expertise spans a wide range of molecular and cell biology techniques, including advanced imaging and bioinformatics.

Accolades and Recognition 🏆

Dr. Wang has made notable contributions to the field through her publications and presentations at various conferences. Her research on lipid-induced contractile dysfunction and diabetic cardiomyopathy has been recognized in leading journals and upcoming publications. Her work is highly regarded in the scientific community, reflecting her commitment to advancing healthcare solutions.

Impact and Influence 🌍

Dr. Wang's research has a profound impact on understanding and treating metabolic disorders, particularly in diabetic cardiomyopathy. Her innovative approaches and exploration of traditional medicine offer promising solutions for improving patient outcomes and advancing the field of metabolic disease research. Her contributions are shaping new therapeutic strategies and enhancing the quality of life for patients.

Legacy and Future Contributions 🚀

Dr. Wang's future endeavors are set to further explore and develop cutting-edge healthcare solutions. Her ongoing research aims to refine treatment strategies for metabolic disorders and improve the efficacy of drug development. By integrating advanced techniques and traditional medicine, she is poised to make significant strides in the field, contributing to a healthier future and advancing scientific knowledge.

 

Publications 📕

  • 📝 Specific Compounds Derived from Traditional Chinese Medicine Ameliorate Lipid-Induced Contractile Dysfunction in Cardiomyocytes
    • Authors: Fang Wang, Dietbert Neumann, Dimitrios Kapsokalyvas, Martijn Hoes, Francesco Schianchi, Jan Glatz, Miranda Nabben, Joost J. F. P. Luiken
    • Journal: International Journal of Molecular Sciences
    • Year: 2024
  • 📝 Glycolysis-Mediated Activation of v-ATPase by Nicotinamide Mononucleotide Ameliorates Lipid-Induced Cardiomyopathy by Repressing the CD36-TLR4 Axis
    • Authors: Shujin Wang, Han YinYing, Ruimin Liu, Hou M, Dietbert Neumann, Jun Zhang, Wang F, Yumeng Li, Zhao X, Francesco Schianchi et al.
    • Journal: Circulation Research
    • Year: 2024
  • 📝 Progestin and adipoQ receptor 7 (PAQR7) mediate the anti-apoptotic effect of P4 on human granulosa cells and its deficiency reduces ovarian function in female mice
    • Authors: Li J, Liu Y, He J, Wu Z, Wang F, Huang J, Zheng L, Luo T
    • Journal: Journal of Ovarian Research
    • Year: 2024
  • 📝 CD36 as a target for metabolic modulation therapy in cardiac disease
    • Authors: Glatz JFC, Wang F, Miranda Nabben, Luiken JJFP
    • Journal: Expert Opinion on Therapeutic Targets
    • Year: 2021
  • 📝 Diet-induced obesity is associated with altered expression of sperm motility-related genes and testicular post-translational modifications in a mouse model
    • Authors: Wang F, Chen H, Chen Y, Cheng Y, Li J, Zheng L, Zeng X, Luo T
    • Journal: Theriogenology
    • Year: 2020

 

Mehlika Dilek Altıntop | Pharmacology, Toxicology and Pharmaceutical Science | Women Research Award

Posted on by Book of Award

Prof Dr. Mehlika Dilek Altıntop | Pharmacology, Toxicology and Pharmaceutical Science | Women Research Award

Anadolu University | Turkey

Author Profile

Scopus

Orcid

Early Academic Pursuits 🎓

Prof. Dr. Mehlika Dilek Altıntop began her academic journey at İkieylül Elementary School (1991-1996) and continued at Eskişehir Anatolian High School (1996-2003). She pursued her undergraduate studies at Anadolu University, Faculty of Pharmacy (2003-2007). Following this, she completed her Master’s degree (with thesis) at Anadolu University, Graduate School of Health Sciences, Department of Pharmaceutical Chemistry (2007-2009). Her doctoral studies were also undertaken at Anadolu University, focusing on Pharmaceutical Chemistry (2009-2012).

Professional Endeavors 🏢

Dr. Altıntop’s professional career began as a Research Assistant at Anadolu University, Faculty of Pharmacy (2010-2012). She advanced to Research Assistant Doctor (2012-2014) and subsequently to Assistant Professor Doctor (2014-2015). She earned her position as Associate Professor Doctor (2015-2020) and was promoted to Professor Doctor (2020-present) at Anadolu University, Faculty of Pharmacy. Her administrative roles include serving as the Erasmus/Farabi/Mevlana Assistant Coordinator (2013-2014), Associate Director of Anadolu University Graduate School of Health Sciences (2014-2017 and 2023), and Quality Coordinator (2022-2023).

Contributions and Research Focus 🔬

Prof. Dr. Altıntop’s research predominantly focuses on pharmaceutical chemistry, medicinal chemistry, and drug development. She has made significant contributions to the synthesis and evaluation of novel compounds with therapeutic potential. Her work includes the development of dual EGFR and Akt inhibitors and small-molecule inhibitors targeting cancer therapy. She has also explored novel metabolic enzyme inhibitors and aldose reductase inhibitors.

Accolades and Recognition 🏆

Dr. Altıntop has received numerous awards for her academic and research achievements:

  • Anadolu University Faculty of Pharmacy Championship Award (2007)
  • Graduate Scholarship from The Scientific and Technological Research Council of Turkey (2007-2009)
  • Anadolu University Science and Technology Encouragement Award (2014)
  • Anadolu University Gold Article Performance Award (2015)
  • Turkish Pharmacists’ Association Academy of Pharmacy Encouragement Award (2019)
  • Outstanding Woman Researcher in Pharmaceutical Chemistry Award (VIWA 2021)
  • ISIF'21 Silver Medal for invention (2021)
  • Top Cited Article Awards (2021-2023)

Impact and Influence 🌟

Dr. Altıntop’s work has had a substantial impact on the field of pharmaceutical chemistry, particularly in the development of novel therapeutic agents for cancer and other diseases. Her role as an Associate Editor and Guest Editor in prestigious journals, as well as her involvement in international scientific committees, highlights her influence and leadership in the field.

Legacy and Future Contributions 🌐

Prof. Dr. Altıntop’s contributions continue to shape the future of pharmaceutical research and drug development. Her ongoing work in medicinal chemistry and her role in mentoring the next generation of researchers underscore her lasting legacy in advancing science and improving healthcare outcomes.

 

Publications

  • 📜Design, Synthesis, and Biological Evaluation of a New Series of Imidazothiazole-Hydrazone Hybrids as Dual EGFR and Akt Inhibitors for NSCLC Therapy
    Authors: Mehlika Dilek Altıntop, İpek Ertorun, Gülşen Akalın Çiftçi, Ahmet Özdemir
    Journal: European Journal of Medicinal Chemistry
    Year: 2024

 

  • 📜Design, Synthesis, and In Vivo Evaluation of a New Series of Indole-Chalcone Hybrids as Analgesic and Anti-Inflammatory Agents
    Authors: Baramaki, I., Altıntop, M.D., Arslan, R., Hasan, A., Bektaş Türkmen, N.
    Journal: ACS Omega
    Year: 2024

 

  • 📜Design, Synthesis, and Evaluation of a New Series of 2-Pyrazolines as Potential Antileukemic Agents
    Authors: Altıntop, M.D., Cantürk, Z., Özdemir, A.
    Journal: ACS Omega
    Year: 2023

 

  • 📜Design, Synthesis, and Evaluation of a New Series of Hydrazones as Small-Molecule Akt Inhibitors for NSCLC Therapy
    Authors: Erdoğan, B., Altıntop, M.D., Akalın Çiftçi, G., Özdemir, A., Ece, A.
    Journal: ACS Omega
    Year: 2023

 

  • 📜A New Series of Hydrazones as Small-Molecule Aldose Reductase Inhibitors
    Authors: Altıntop, M.D., Demir, Y., Türkeş, C., Beydemir, Ş., Özdemir, A.
    Journal: Archiv der Pharmazie
    Year: 2023

 

  • 📜A New Series of Thiazole-Hydrazone Hybrids for Akt-Targeted Therapy of Non-Small Cell Lung Cancer
    Authors: Orujova, T., Ece, A., Akalın Çiftçi, G., Özdemir, A., Altıntop, M.D.
    Journal: Drug Development Research
    Year: 2023

Ahmet Özdemir | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Posted on by Book of Award

Prof Dr. Ahmet Özdemir | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Anadolu University | Turkey

Author Profile

Scopus

Orcid

Early Academic Pursuits 🎓

Prof. Dr. Ahmet Özdemir's academic journey began at Salihli Cumhuriyet Elementary School (1978-1983), followed by Salihli 50. Yıl Secondary School (1983-1986) and Salihli High School (1986-1989). His passion for pharmacy led him to Anadolu University Faculty of Pharmacy, where he completed his undergraduate studies (1990-1994). He pursued further education at the Graduate School of Health Sciences, Department of Pharmaceutical Chemistry at Anadolu University, earning a Master's degree (1995-1996) and a Doctor's degree (1996-2004).

Professional Endeavors 💼

Prof. Dr. Özdemir's professional career commenced at Anadolu University as a Research Assistant (1997-2004). He progressed to Research Assistant Doctor (2004-2005), Lecturer (2005-2007), and Assistant Professor Doctor (2007-2010). His dedication and expertise earned him the title of Associate Professor Doctor (2010-2015), and he has been serving as a Professor Doctor since 2015.

Contributions and Research Focus 🔍

Prof. Dr. Özdemir's research is marked by significant contributions to pharmaceutical chemistry. His Master's thesis focused on "The studies on the synthesis, structure elucidations and determination of physicochemical parameters of some 2-substituted-1H-phenantro[9,10-d]imidazole compounds," under the supervision of Prof. Dr. İlhan Işıkdağ. His PhD thesis, supervised by Prof. Dr. Gülhan Turan, investigated the "Synthesis of some 1-[(N,N-disubstituted-thiocarbonylthio)acetyl]-3-(2-thienyl)-5-aryl-2-pyrazoline derivatives and their antifungal, antibacterial activities."

Accolades and Recognition 🏅

Prof. Dr. Özdemir's work has been widely recognized, earning him numerous awards:

  • Anadolu University Article Performance Award (2014, 2016, 2017, 2018, 2020)
  • Anadolu University Gold Article Performance Award (2015)
  • Anadolu University Platinum Article Performance Award (2015)
  • Anadolu University Academic Success Award (2019)
  • ISIF'21 Silver Medal for the invention "Targeted Novel Triazolothiadiazine Derivatives for The Treatment of Lung Cancer" (2021)

Impact and Influence 🌟

Prof. Dr. Özdemir's impact extends beyond research. He has held key administrative roles, including Associate Director of Anadolu University Yunus Emre Vocational School (2011-2014) and Vice Academic Director of the Anadolu University Open Education Faculty, Department of Health Administration (2015-present). His mentorship has guided many students, as evidenced by his supervision of numerous master’s and doctoral dissertations.

Legacy and Future Contributions 🚀

Prof. Dr. Özdemir’s legacy is built on his unwavering commitment to advancing pharmaceutical chemistry. His innovative research, administrative leadership, and dedication to education have left an indelible mark on Anadolu University and the broader scientific community. As he continues his work, Prof. Dr. Özdemir is poised to make further groundbreaking contributions that will shape the future of pharmaceutical sciences.

 

Publications

📜Title: Design, Synthesis, and Biological Evaluation of a New Series of Imidazothiazole-Hydrazone Hybrids as Dual EGFR and Akt Inhibitors for NSCLC Therapy
Authors: Mehlika Dilek Altıntop, İpek Ertorun, Gülşen Akalın Çiftçi, Ahmet Özdemir
Journal: European Journal of Medicinal Chemistry
Year: 2024

📜Title: Design, Synthesis, and In Vivo Evaluation of a New Series of Indole-Chalcone Hybrids as Analgesic and Anti-Inflammatory Agents
Authors: Baramaki, I., Altıntop, M.D., Arslan, R., Hasan, A., Bektaş Türkmen, N.
Journal: ACS Omega
Year: 2024

📜Title: Design, Synthesis, and Evaluation of a New Series of 2-Pyrazolines as Potential Antileukemic Agents
Authors: Altıntop, M.D., Cantürk, Z., Özdemir, A.
Journal: ACS Omega
Year: 2023

📜Title: Design, Synthesis, and Evaluation of a New Series of Hydrazones as Small-Molecule Akt Inhibitors for NSCLC Therapy
Authors: Erdönmez, B., Altıntop, M.D., Akalın Çiftçi, G., Özdemir, A., Ece, A.
Journal: ACS Omega
Year: 2023

📜Title: A New Series of Hydrazones as Small-Molecule Aldose Reductase Inhibitors
Authors: Altıntop, M.D., Demir, Y., Türkeş, C., Beydemir, Ş., Özdemir, A.
Journal: Archiv der Pharmazie
Year: 2023

📜Title: A New Series of Thiazole-Hydrazone Hybrids for Akt-Targeted Therapy of Non-Small Cell Lung Cancer
Authors: Orujova, T., Ece, A., Akalın Çiftçi, G., Özdemir, A., Altıntop, M.D.
Journal: Drug Development Research
Year: 2023